training kit, CHF1535 pMDI 100/6, CHF5993 pMDI-US
CLI-05993AA3-06
Phase 3 small_molecule active
Quick answer
training kit, CHF1535 pMDI 100/6, CHF5993 pMDI-US for Chronic obstructive pulmonary disease (COPD) is a Phase 3 program (small_molecule) at Chiesi Farmaceutici S.p.A with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chiesi Farmaceutici S.p.A
- Indication
- Chronic obstructive pulmonary disease (COPD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active